187 related articles for article (PubMed ID: 16860457)
41. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Gianni L; Baselga J; Eiermann W; Porta VG; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Cussac AL; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez JJ; Mansutti M; Valagussa P; Bonadonna G
J Clin Oncol; 2009 May; 27(15):2474-81. PubMed ID: 19332727
[TBL] [Abstract][Full Text] [Related]
42. Doxorubicin and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial.
Jassem J; Pienkowski T; Pluzanska A; Jelic S; Gorbunova V; Berzins J; Nagykalnai T; Biganzoli L; Aloe A; Astier L; Munier S
Onkologie; 2009 Sep; 32(8-9):468-72. PubMed ID: 19745590
[TBL] [Abstract][Full Text] [Related]
43. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
44. Leukaemia cutis in a patient treated for breast cancer.
Weinel S; Malone J; Jain D; Callen JP
Australas J Dermatol; 2009 Feb; 50(1):52-5. PubMed ID: 19178494
[TBL] [Abstract][Full Text] [Related]
45. Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).
Linden HM; Haskell CM; Green SJ; Osborne CK; Sledge GW; Shapiro CL; Ingle JN; Lew D; Hutchins LF; Livingston RB; Martino S
J Clin Oncol; 2007 Feb; 25(6):656-61. PubMed ID: 17308269
[TBL] [Abstract][Full Text] [Related]
46. Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.
Coccaro M; Gallucci G
J Clin Oncol; 2008 Jul; 26(19):3288; author reply 3289. PubMed ID: 18591567
[No Abstract] [Full Text] [Related]
47. Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.
Tolaney SM; Partridge AH; Sheib RG; Burstein HJ; Winer EP
J Clin Oncol; 2006 Nov; 24(33):5330-1. PubMed ID: 17114668
[No Abstract] [Full Text] [Related]
48. Anthracyclines for gestational breast cancer: course and outcome of pregnancy.
Azim HA; Peccatori FA; Scarfone G; Acaia B; Rossi P; Cascio R; Goldhirsch A
Ann Oncol; 2008 Aug; 19(8):1511-1512. PubMed ID: 18562327
[No Abstract] [Full Text] [Related]
49. [Diagnosis and treatment of pregnancy-associated breast cancer].
Dashian GA; Semiglazov VF; Semiglazov VV; Topuzov ÉÉ; Krivorot'ko PV; Donskikh RV; Tabagua TT; Grechukhina IA; Dzhukaeva TsS
Vopr Onkol; 2011; 57(5):584-91. PubMed ID: 22238927
[No Abstract] [Full Text] [Related]
50. Extramedullary hematopoiesis in breast after neoadjuvant chemotherapy for breast carcinoma.
Wang J; Darvishian F
Ann Clin Lab Sci; 2006; 36(4):475-8. PubMed ID: 17127738
[TBL] [Abstract][Full Text] [Related]
51. Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
Ganz PA; Hussey MA; Moinpour CM; Unger JM; Hutchins LF; Dakhil SR; Giguere JK; Goodwin JW; Martino S; Albain KS
J Clin Oncol; 2008 Mar; 26(8):1223-30. PubMed ID: 18227530
[TBL] [Abstract][Full Text] [Related]
52. Epirubicin for breast cancer during pregnancy: a case report.
Eedarapalli P; Biswas N; Coleman M
J Reprod Med; 2007 Aug; 52(8):730-2. PubMed ID: 17879836
[TBL] [Abstract][Full Text] [Related]
53. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Hess KR; Anderson K; Symmans WF; Valero V; Ibrahim N; Mejia JA; Booser D; Theriault RL; Buzdar AU; Dempsey PJ; Rouzier R; Sneige N; Ross JS; Vidaurre T; Gómez HL; Hortobagyi GN; Pusztai L
J Clin Oncol; 2006 Sep; 24(26):4236-44. PubMed ID: 16896004
[TBL] [Abstract][Full Text] [Related]
54. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
55. Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report.
Palaia I; Pernice M; Graziano M; Bellati F; Panici PB
Am J Obstet Gynecol; 2007 Oct; 197(4):e5-6. PubMed ID: 17904952
[TBL] [Abstract][Full Text] [Related]
56. Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
Abu-Khalaf MM; Juneja V; Chung GG; DiGiovanna MP; Sipples R; McGurk M; Zelterman D; Haffty B; Reiss M; Wackers FJ; Lee FA; Burtness BA
Breast Cancer Res Treat; 2007 Sep; 104(3):341-9. PubMed ID: 17051423
[TBL] [Abstract][Full Text] [Related]
57. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
[TBL] [Abstract][Full Text] [Related]
58. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
59. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
Trudeau ME; Clemons MJ; Provencher L; Panasci L; Yelle L; Rayson D; Latreille J; Vandenberg T; Goel R; Zibdawi L; Rahim Y; Pouliot JF
J Clin Oncol; 2009 Dec; 27(35):5906-10. PubMed ID: 19858391
[TBL] [Abstract][Full Text] [Related]
60. Delays in diagnosing breast cancer--the impact of concurrent pregnancy and lactation.
Saunders C; Ives A; Puckridge P; Semmens J
Aust N Z J Obstet Gynaecol; 2002 Nov; 42(5):573-5. PubMed ID: 12495121
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
